Ionis Pharmaceuticals reported $2.36B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Agios Pharmaceuticals USD 752.1M 34.43M Sep/2026
Alnylam Pharmaceuticals USD 5.11B 492.49M Sep/2026
Arrowhead Research USD 1.29B 382.19M Sep/2026
Astellas Pharma JPY 1.44T 41.22B Sep/2026
BioCryst Pharmaceuticals USD 531.15M 46.47M Sep/2026
BioMarin Pharmaceutical USD 3.92B 50.99M Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Exelixis USD 1.32B 70.8M Sep/2026
Halozyme Therapeutics USD 1.85B 913.71M Sep/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Moderna USD 7.34B 1.53B Sep/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Neurocrine Biosciences USD 2.01B 370.7M Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Omeros USD 69.65M 26.53M Jun/2025
OPKO Health USD 500.24M 35.13M Jun/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 45.01B 3.65B Sep/2026
Pharma Mar EUR 295.56M 14.62M Sep/2026
PTC Therapeutics USD 2.54B 79.58M Sep/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Regeneron Pharmaceuticals USD 20.8B 2.35B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sarepta Therapeutics USD 2.27B 49.06M Sep/2026
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Tilray USD 729.32M 28.18M Sep/2025
Ultragenyx Pharmaceutical USD 544M 62M Sep/2026
Vertex Pharmaceuticals USD 11.69B 857.4M Sep/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026